Glenohumeral arthritis in the young patient presents a difficult problem with potentially devastating sequelae.
Introduction
Management of glenohumeral arthritis in the young patient is a difficult challenge. Numerous etiologies exist, including idiopathic, inflammatory, autoimmune disorders, postinfectious, shoulder instability, and even iatrogenic causes. Early stage, minor joint changes can be treated nonoperatively. More advanced disease that causes pain or leads to limitation or loss of function needs to be evaluated carefully. Any treatment plan requires consideration for the long and seemingly productive remaining life of the affected joint and patient. Traditional total joint arthroplasty has historically relieved pain, but results in younger patients are not as favorable, with higher incidence of component failure and worse outcome scores [9, 16] . Younger patients particularly interested in maintaining an active lifestyle may wish to delay total joint arthroplasty. In younger patients more conservative measures need to be exhausted prior to proceeding with arthroplasty.
The role of arthroscopy is expanding in the management of glenohumeral arthritis. Early degenerative joint disease can mimic or coexist with other pathologic diagnoses, such as impingement [2, 6, 8] . For early stage arthritis, particularly small focal lesions not easily elucidated by plain radiographs or MR imaging, arthroscopy can be an important diagnostic tool [2] . Arthroscopic débridement of the glenohumeral joint is an expanding option in the treatment of shoulder arthritis. It improves pain and function, with the best results in those shoulders with mild to moderate arthritic changes [19, 27] . However, the literature is not clear on whether the grade of the lesion influences outcome or whether the presence of a lesion on one versus both sides of the joint influences outcome.
We therefore compared patients with high grade lesions (Grade 4) to those with low grade lesions (Grades 2 and 3). Additionally, we compared patients with unipolar glenohumeral cartilage lesions with patients with bipolar lesions after undergoing arthroscopic débridement to determine if better outcomes can be expected in those patients with less severe disease.
Materials and Methods
We retrospectively reviewed 19 patients (20 shoulders) who underwent arthroscopic shoulder surgery during which débridement of the glenohumeral joint was performed for Outerbridge between May 2004 and October 2006. We compared outcome measures for patients with Grades 2-3 to those in patients with Grade 4 lesions and the outcomes for patients with monopolar versus bipolar lesions. The primary complaint in most patients was pain rather than loss of motion. We included all patients aged 18 to 55 years for whom nonoperative treatment failed. Patients with concomitant rotator cuff repairs were not included. There were 12 men and seven women in the study group. Three of the 19 patients (three shoulders) underwent prosthetic replacement during the study period. We did not include their outcome measurements, as we considered these patients to have failed treatment. The average age was 38 years (range, 20-54 years). The minimum follow up time was 12 months (average, 20 months; range, 12-33 months).
Preoperative plain film imaging was obtained in all patients. OA was not apparent in 12 of 19 patients. Some showed no evidence of degenerative changes.
All patients underwent shoulder arthroscopy in the beach-chair position. Standard posterior viewing and anterior working portals were used for the diagnostic arthroscopy.
The grade, location, size, and number of each cartilage defect were noted using a clock face arrangement for location and calibrated probe for size. We used the Outerbridge grading scale [20] ; in Grade 1 there is softening and swelling of the cartilage; in +Grade 2 there is fissuring and fragmentation in an area less than one-half inch in diameter; Grade 3 has the same findings as Grade 2 but greater than one-half inch diameter; Grade 4 has erosion to bone. Four patients had Grade 2 or 3 lesions and 15 had Grade 4 articular cartilage changes. We arthroscopically débrided the lesions to remove any loose cartilaginous fragments, leaving a stable edge.
Sixteen of the 19 patients underwent concomitant procedures as determined by preoperative evaluations and diagnoses. A biceps tenotomy was performed in five patients. This decision was made intraoperatively after probing the biceps insertion for tearing; however, each patient was alerted preoperatively to the possibility of tenotomy if significant biceps insertion pathology was identified. One patient underwent repair of a Type II SLAP lesion. A distal clavicle resection was performed in two patients. In nine patients an acromioplasty was performed. Four patients underwent subacromial bursectomy without acromioplasty. Two patients required a manipulation under anesthesia at the time of surgery. A microfracture was performed in two patients who had focal Grade 4 lesions with stable surrounding edges, without any other degenerative findings.
Postoperatively, patients were placed in a sling for comfort. Passive shoulder range of motion began on the first postoperative day. The sling was discontinued when tolerated by the patient, and active range of motion began when pain allowed (except for patients undergoing SLAP repair, for which no active biceps motion was allowed for 6 weeks).
Potential study participants were mailed questionnaires approved by our institutional review board. The Western Ontario Osteoarthritis Score (WOOS) [12] , Marx Activity Level Score [4] , American Shoulder and Elbow Society (ASES) Score [11] , SANE Score [28] and SF-12 forms [26] were completed by the patients. They were instructed to complete and return the questionnaires but provide no other instructions.
We compared WOOS scores, ASES scores, Marx Activity Level scores, and SANE scores for patients with Grade 2-3 lesions and those with Grade 4 lesions and patients with monopolar and bipolar lesions using a t test. We chose this test because the variance between the two groups showed no evidence that they were not normally distributed.
Results
The mean WOOS score for the 16 included patients was 0.64 (range, 0.12-0.98). The mean ASES score was 75.3 (range, 24-100). The Marx Activity Level Score was 12.6 (range 9.0 to 18.0). The SANE (Single Assessment Numeric Evaluation) score (for which patients were asked ''On a scale of 0 to 100, how would you rate your shoulder function with 100 being normal?'') was 71%. When one patient who rated his function as 0% was excluded, the SANE score rose to 77% (Table 1) . Overall, nine patients rated their shoulder function at 80% or better by SANE score. Five of these patients had Grade 4 changes. At final followup, all nine of these patients had forward flexion to at least 170°and external rotation to at least 70°. Two patients rated their shoulder function at 30% or worse; both had bipolar lesions.
Patients with Grade 4 lesions had similar outcome scores in all measures as those with Grade 2 or 3 cartilage changes ( Table 2) . WOOS scores averaged 0.66 for those with Grade 2 or 3 changes, compared to 0.64 for patients with Grade 4 disease. ASES scores were similar for both groups (Grade 2/3, 75.9; Grade 4, 75.4). Marx Activity Level scores averaged 14.7 for the low grade group and 11.9 for the high grade patients. None of these values were significant (p = 0.91, p = 0.97, p = 0.15, respectively). SANE scores were not markedly higher in the Grade 2/3 shoulders (68.8 versus 60.6, p = 0.69). The group with Grade 2 or 3 changes (mean age, 27.8 years) was noticeably younger than the group with Grade 4 changes (mean age, 47.5 years, p = 0.017).
Patients with unipolar lesions of either the glenoid or humeral head fared considerably better compared to those with bipolar lesions in WOOS and SANE scores ( Table 3 ). There were seven patients (eight shoulders) with unipolar lesions and nine patients with bipolar cartilage lesions.
WOOS scores averaged 0.89 for patients with unipolar lesions and 0.52 for those with bipolar lesions (p = 0.014). ASES scores were 93.3 and 66.3 for unipolar and bipolar groups, respectively (p = 0.033). SANE ratings were also better in the unipolar group (89.6 versus 49.3; p = 0.022). Marx score comparisons, although lacking a significant p value difference, showed a definite trend toward higher scores in the unipolar group (14.4 versus 11.3 for the bipolar group, p = 0.053).
Discussion
We sought to identify prognostic factors in determining outcomes in patients treated surgically for glenohumeral cartilage lesions. This study has several limitations. First, it is a retrospective review. As such, it was difficult to control for specifically separating diagnoses and their different treatments when these separate diagnoses are often treated with concomitant procedures during the same surgery. Second, the small sample sizes limited the power of the study. Comparing patients undergoing different concomitant procedures in addition to the arthroscopic débridements may impair the comparisons somewhat.
Various etiologies lead to premature degenerative glenohumeral joint disease. Glenohumeral arthrosis following instability episodes has often been described in the literature. ''Dislocation arthropathy'' occurs in patients treated nonoperatively and operatively. Intraarticular changes may occur following a single dislocation, and can worsen with subsequent instability episodes [8, 10, 15, 18, 24] .
Glenohumeral arthritis is a well-described complication of stabilization procedures for glenohumeral instability. Neer et al. [17] noted 10% of their patients undergoing total shoulder arthroplasty for degenerative arthritis had prior surgery for shoulder instability. Green and Norris [9] reviewed a series of 39 patients with advanced glenohumeral arthritis and a history of instability. Nineteen of these patients had previously undergone stabilization procedures.
Managing young patients with glenohumeral arthritis is a difficult problem. The treatment needs to be tailored to the stage of the patient's disease process. Patients with relatively little pain and good function can be followed nonoperatively, with focus on maintenance of strength and capsular mobility. Additionally, nonsteroidal anti-inflammatory drugs, COX-2 specific drugs, and corticosteroid injections can be utilized for temporary relief of symptomatic flare-ups. To date, the use of viscosupplementation is considered off-label for the glenohumeral joint, but has been described as an option with successful results [25] .
When glenohumeral arthritis in the young patient becomes refractory to nonoperative management, conservative surgical intervention is indicated. With worsening mechanical symptoms or stiffness, arthroscopic glenohumeral débridement can be considered [5] . Most experience reported in the literature supports arthroscopic débridement for early-stage arthritic changes in the shoulder. Ogilvie-Harris and Wiley [19] first reported on a series of 54 patients undergoing arthroscopic shoulder débridement with 3-year followup. Two-thirds of their patients with mild degenerative disease achieved a successful result, while only one-third of those with moderate to severe disease had a good result.
Weinstein et al. [27] noted good outcomes in a study of 25 patients undergoing arthroscopic glenohumeral débridement. The average age of the study group was 46 years (range, 27-72 years). All patients reported at least some improvement in pain. At final followup, only two patients had reported return of pain to preoperative levels. They also noted a trend between severity of articular cartilage damage and worse unfavorable results. They recommended arthroscopic débridement as a reasonable approach to treating mild glenohumeral arthritis, and recommended against it in patients with severe joint incongruity or radiographic loss of joint space.
Cameron et al. [7] reported on arthroscopic débridement of Grade 4 glenohumeral articular lesions. They noted relief of pain for a mean of 28 months or greater in their series. They also reported lesions greater than 2 cm 2 correlated with lesser duration of pain relief and were predictive for ultimate failure of the procedure.
If stiffness, particularly in external rotation, is a major issue, arthroscopic or open release can be performed. MacDonald et al. [14] reported good results after performing subscapularis release in 10 patients who developed mild to severe arthritic changes in the shoulder following anterior stabilization. These patients had increased external rotation and pain relief at an average of 3.5 years postoperatively. Lusardi et al. [13] also recommended an anterior release for patients with a major loss of external rotation to prevent late osteoarthrosis in patients who previously underwent shoulder stabilization procedures. Additionally, Cameron et al. [7] recommended adding capsular release to arthroscopic débridement if there was loss of motion greater than 15°in any plane of motion.
When less diffuse, focal cartilage lesions are found in isolation, marrow stimulation or restorative cartilage transplantation can be considered. Microfracture [23] and autologous chondrocyte transplantation (ACI) [22] have been described as effective surgical options in the shoulder. Interposition allografts, performed either arthroscopically or with an open approach, have been effectively utilized in the glenohumeral joint [1, 3, 6, 21] .
Our results mirrored those of previous studies, suggesting arthroscopic débridement of lower-grade glenohumeral cartilage lesions resulted in symptomatic pain relief and improved function. However, contrary to prior reports, many of our patients with higher-grade lesions did have outcomes comparable to those with lower-grade lesions, with SANE scores of 80% or higher. Those patients with unipolar lesions demonstrated much higher outcome scores compared to those with bipolar cartilage lesions. Nevertheless, three patients to date have progressed to shoulder resurfacing or arthroplasty. We counsel our patients that arthroscopic glenohumeral débridement can offer improvement in pain and function, but the extent and duration of that relief is related to the degree of joint degeneration. Regardless, this relatively conservative surgical option, combined with associated procedures pertinent to each individual patient's needs (acromioplasty, microfracture, etc.) can provide temporary relief and delay the need for more involved reconstructive arthroplasty.
